Back to today’s briefing

Story perspectives

UK NHS Launches Mounjaro Amid Safety Concerns

6/30/2025

50 7

Summary

Story summary

The UK NHS is introducing Mounjaro, a weight loss drug, despite safety worries. GLP-1 medications have been linked to hundreds of pancreatitis cases, including five deaths. In response, the MHRA is probing genetic factors behind these risks and encourages patients to report any adverse effects to enhance safety measures.

1 of 1

Story summary

The UK NHS is introducing Mounjaro, a weight loss drug, despite safety worries. GLP-1 medications have been linked to hundreds of pancreatitis cases, including five deaths. In response, the MHRA is probing genetic factors behind these risks and encourages patients to report any adverse effects to enhance safety measures.